1: Wiederhold NP. Review of T-2307, an Investigational Agent That Causes Collapse of Fungal Mitochondrial Membrane Potential. J Fungi (Basel). 2021 Feb 11;7(2):130. doi: 10.3390/jof7020130. PMID: 33670132; PMCID: PMC7916847.
2: Abe M, Nakamura S, Kinjo Y, Masuyama Y, Mitsuyama J, Kaku M, Miyazaki Y. Efficacy of T-2307, a novel arylamidine, against ocular complications of disseminated candidiasis in mice. J Antimicrob Chemother. 2019 May 1;74(5):1327-1332. doi: 10.1093/jac/dkz020. PMID: 30753506.
3: Yamashita K, Miyazaki T, Fukuda Y, Mitsuyama J, Saijo T, Shimamura S, Yamamoto K, Imamura Y, Izumikawa K, Yanagihara K, Kohno S, Mukae H. The Novel Arylamidine T-2307 Selectively Disrupts Yeast Mitochondrial Function by Inhibiting Respiratory Chain Complexes. Antimicrob Agents Chemother. 2019 Jul 25;63(8):e00374-19. doi: 10.1128/AAC.00374-19. PMID: 31182539; PMCID: PMC6658782.
4: Wiederhold NP, Najvar LK, Jaramillo R, Olivo M, Patterson H, Connell A, Fukuda Y, Mitsuyama J, Catano G, Patterson TF. The Novel Arylamidine T-2307 Demonstrates In Vitro and In Vivo Activity against Candida auris. Antimicrob Agents Chemother. 2020 Feb 21;64(3):e02198-19. doi: 10.1128/AAC.02198-19. PMID: 31844006; PMCID: PMC7038306.
5: Nishikawa H, Sakagami T, Yamada E, Fukuda Y, Hayakawa H, Nomura N, Mitsuyama J, Miyazaki T, Mukae H, Kohno S. T-2307, a novel arylamidine, is transported into Candida albicans by a high-affinity spermine and spermidine carrier regulated by Agp2. J Antimicrob Chemother. 2016 Jul;71(7):1845-55. doi: 10.1093/jac/dkw095. Epub 2016 Apr 18. PMID: 27090633.
6: Shibata T, Takahashi T, Yamada E, Kimura A, Nishikawa H, Hayakawa H, Nomura N, Mitsuyama J. T-2307 causes collapse of mitochondrial membrane potential in yeast. Antimicrob Agents Chemother. 2012 Nov;56(11):5892-7. doi: 10.1128/AAC.05954-11. Epub 2012 Sep 4. PMID: 22948882; PMCID: PMC3486560.
7: Wiederhold NP, Najvar LK, Fothergill AW, Bocanegra R, Olivo M, McCarthy DI, Fukuda Y, Mitsuyama J, Patterson TF. The novel arylamidine T-2307 demonstrates in vitro and in vivo activity against echinocandin-resistant Candida glabrata. J Antimicrob Chemother. 2016 Mar;71(3):692-5. doi: 10.1093/jac/dkv398. Epub 2015 Nov 29. PMID: 26620102; PMCID: PMC4743701.
8: Nishikawa H, Yamada E, Shibata T, Uchihashi S, Fan H, Hayakawa H, Nomura N, Mitsuyama J. Uptake of T-2307, a novel arylamidine, in Candida albicans. J Antimicrob Chemother. 2010 Aug;65(8):1681-7. doi: 10.1093/jac/dkq177. Epub 2010 May 30. PMID: 20513704.
9: Yamada E, Nishikawa H, Nomura N, Mitsuyama J. T-2307 shows efficacy in a murine model of Candida glabrata infection despite in vitro trailing growth phenomena. Antimicrob Agents Chemother. 2010 Sep;54(9):3630-4. doi: 10.1128/AAC.00355-10. Epub 2010 Jun 14. PMID: 20547803; PMCID: PMC2935006.
10: Nishikawa H, Fukuda Y, Mitsuyama J, Tashiro M, Tanaka A, Takazono T, Saijo T, Yamamoto K, Nakamura S, Imamura Y, Miyazaki T, Kakeya H, Yamamoto Y, Yanagihara K, Mukae H, Kohno S, Izumikawa K. In vitro and in vivo antifungal activities of T-2307, a novel arylamidine, against Cryptococcus gattii: an emerging fungal pathogen. J Antimicrob Chemother. 2017 Jun 1;72(6):1709-1713. doi: 10.1093/jac/dkx020. PMID: 28201509; PMCID: PMC5890668.